Elimination of lipid levels from quality measures: implications and alternatives

MeSH terms

• Accountable Care Organizations / standards*
• Centers for Medicare and Medicaid Services, U.S.
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
• Hyperlipidemias / complications
• Hyperlipidemias / drug therapy*
• Lipids / blood*
• Quality Indicators, Health Care*
• Risk Assessment
• United States